The clinical trials with an agent like this are pretty straightforward and the Advisory Committee agreed that, in terms of clinical efficacy, degludec meets the guidelines for approval.
FORBES: FDA Panel Backs New Diabetes Drug: Will CV Study Be Needed Before Approval?